The Zhitong Finance App learned that on Wednesday, the stock price of Wanda Biopharmaceuticals (VNDA.US) rose. As of press release, the stock had risen more than 32% to $9.33. According to the news, the company said that its new drug, Nereus, has been approved by the US Food and Drug Administration (FDA), and that the drug can be used to prevent exercise-induced vomiting.

The Zhitong Finance App learned that on Wednesday, the stock price of Wanda Biopharmaceuticals (VNDA.US) rose. As of press release, the stock had risen more than 32% to $9.33. According to the news, the company said that its new drug, Nereus, has been approved by the US Food and Drug Administration (FDA), and that the drug can be used to prevent exercise-induced vomiting.